Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin for treatment of bacterial otitis media
IRCT20130427013136N7Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Sep 2018
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ciprofloxacin in chronic suppurative otitis media (CSOM), sponsored by Babol University of Medical Sciences. Started Sep 2018; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
chronic suppurative otitis media (CSOM)
Beyond the preview
Go deeper on IRCT20130427013136N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130427013136N7.